Press release
Chagas Disease Treatment Market - Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
In 2017, Food and Drug Administration (FDA) approved benznidazole for children suffering from Chagas, in the age group of 2 to 12 years. This is the first approved safe and effective therapeutic for Chagas in the U.S. FDA granted benznidazole priority review and orphan product designation, as it is a rare disease and there have been no approved drugs for its treatment in the U.S. This approval is expected to influence manufacturers to develop new drugs and biological products for the prevention and treatment of rare diseases. Some of the major players operating in the global chagas disease treatment market are F. Hoffmann-La Roche Ltd., KaloBios Pharmaceuticals, Inc., Johnson & Johnson, Bayer AG., and ELEA SACIF Laboratory.Ask for detailed Sample of the Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/934
“The Sample consists of Table of Content, Research framework of the actual report & research methodology adopted for it”
Adoption of nitro derivative compound drugs associated with the host immune response, help prevent the disease and avoid parasite proliferation. Drugs used in the treatment of Chagas disease include benznidazole and nifurtimox, however, these are associated with serious side effects such as headaches, skin rashes, photosensitivity, chest pain, dizziness, nausea, insomnia, and jaundice. This poses as a restraining factor for growth of the market. No drug has developed so far, has been able to completely cure the disease. This, however, provides market players with lucrative opportunities by working towards development of effective drugs to treat Chagas.
American trypanosomiasis, also referred to as Chagas disease, is caused by the parasite Trypanosoma cruzi (T.cruzi), which is transmitted by the bite of triatomine bugs. T. cruzi can also be transmitted by food contaminated with the parasite, blood transfusion, transmission from infected mother to newborn during gestational period, organ transplant, and laboratory accidents. Symptoms associated with Chagas are not severe and often left undiagnosed. The parasites hide mainly in the heart and digestive muscles during the chronic phase of the disease. Years after the onset of the chronic infection, diseases such as heart diseases (30%), megacolon, and megaseophagus are caused. Chagas disease is one of the most neglected parasitic infections in the U.S., however, it is targeted by the Center for Disease Control and Prevention (CDC) for community health action.
To know more about the Chagas Disease Treatment Market, click the link below: https://www.coherentmarketinsights.com/ongoing-insight/chagas-disease-treatment-market-934
According to Food and Drug Administration (FDA), in 2017, around 300,000 people are estimated to be affected by Chagas disease in the U.S. Furthermore, World Health Organization (WHO) stated that, around 6 million to 7 million people are expected to be affected by Chagas disease in 2017, worldwide. Vector control is the most useful method to prevent the spread of Chagas disease, especially used in Latin America. High incidence rate and easy transmission mode of the disease is expected to increase the demand for treatment of Chagas disease. Non availability of vaccines and biological treatments are expected to create high opportunity for the market players.
Chagas Disease Treatment Market Taxonomy
By Distribution Channel: Hospital Pharmacy,Retail Pharmacy,.
By Region:North America,Europe,Asia Pacific,Latin America,Middle East,Africa,.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
1001 4th Ave,
#3200
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chagas Disease Treatment Market - Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025 here
News-ID: 1030675 • Views: …
More Releases from CMI Research By Healthcare

Electrosurgery Market – Global Industry Insights, Trends, Outlook and Analysis …
Electrosurgery involves application of electrical current to a biological tissue to cut, coagulate, desiccate or fulgurate. Electricity is used to cause thermal destruction of tissue through dehydration, coagulation, or vaporization. The tissue acts as a resistance to the passing current and converts it into heat. High-frequency electro surgery and electro cautery are the two types of electrosurgeries used.
Electro surgery has a wide range of applications in teeth related procedures, laparoscopy,…

eClinical Solutions Market — Global Industry Insights, Trends, Outlook, and An …
eClinical Solutions is used to enhance the clinical development process through data analysis and data management. It provides total transparency and utilization of the operational and clinical data. The solution provider does this by providing data management solutions and customized data management services, that includes clinical reporting, electronic data capture (EDC), data standardization, data management, and clinical data repository platform. The applications and advantages of eClinical solutions helps users to…

ECG Cable and ECG Lead Wires Market – Global Industry Insights, Trends, and Op …
Electrocardiograph machines are used to measure the electrical activity of a patient’s heart. The electrical activity of the heart is recorded with the help of 12-lead ECGs and 10 electrodes placed on patient’s limbs and surface of the chest. Furthermore, ECG applies to monitor the patient’s emergency situation to obtain quick results of heart’s size, position of heart chambers, the rate of the heart, rhythm, and any damage to heart…

Drug for Abuse Testing Devices Market - Global Industry Insights, Trends, Outloo …
Drugs for abuse testing device offer testing methods to detect drugs present in the human body by analyzing saliva, blood, urine, and sweat. The drug for abuse testing devices market comprises kits and devices, which help in measuring drug intake. Tests can be conducted at home as well as in laboratories. The test uses immunoassay to screen different samples and includes the confirmation of screening results by definitive analytical techniques…
More Releases for Chagas
Chagas Disease Treatment Market: An In-Depth Analysis
The global Chagas Disease Treatment Market was valued at approximately USD 450 million in 2024 and is projected to reach around USD 700 million by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033 .
Chagas Disease Treatment Market Overview
Chagas disease, caused by the Trypanosoma cruzi parasite, remains a significant public health challenge, particularly in Latin America. The market's growth is driven by increasing awareness,…
Chagas Disease Drug Market Size, Share, Growth Forecast 2023-2032
Chagas disease, caused by the parasite Trypanosoma cruzi, remains a significant public health concern, particularly in Latin America. With an estimated 6 to 7 million people worldwide affected by this neglected tropical disease, the demand for effective treatments has spurred the growth of the Chagas Disease Drug Market. As of 2022, the market size stood at a commendable USD 265.2 million, and projections indicate a robust expansion, with expectations to…
Chagas Disease Drug Market Size To Touch USD 520.4 Million By 2032
Chagas Disease Drug Market Size to Occupy More Than USD 520.4 Million by 2032 | CAGR 7.1% from 2023 to 2032
The Chagas Disease Drug Market research report published by Acumen Research and Consulting provides a comprehensive yet detailed analysis of the global market landscape. The report helps our clients understand the market scenario while also providing a detailed historical account of the market over the previous years. The Chagas Disease…
2018 – 2024 Chagas Disease Management Market | Global Industry Report
2018 – 2024 Chagas Disease Management Market | Global Industry Report
A Recent Market Study On Chagas Disease And Its Current Trends And Future Insights
Chagas disease or American trypanosomiasis is a tropical parasitic disease caused by Trypanosoma cruzi. It is transmitted by kissing bugs or triatomine bugs. It can also be transmitted through blood transfusions, in pregnancy, and organ transplantation. In early stage of the Chagas disease, the symptoms include swollen…
Chagas Disease Treatment Market Global Industry Insights, and Forecast till 2025
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,…
Chagas Disease Treatment Market - Global Industry Insights, and Forecast till 20 …
Chagas disease is an endemic in 21 Latin American countries caused by kinetoplastid protozoan parasite, Trypanosoma cruzi, primarily transmitted by large, blood-sucking reduviid insects widely known as 'the kissing bugs'. Moreover, the disease can be transferred through other means such as blood transfusion, organ transplantation, as well as congenital and oral transmissions. The recent past has witnessed spread of Chagas disease to developed economies such as Europe and North America,…